Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Biologics are key in current Crohn's disease (CD) treatment but add complexity to therapy selection.
To date, a significant proportion of patients are unresponsive to biological compounds.
It is, therefore, necessary to find alternative options with promising efficacy and safety profiles to increase the chances of achieving durable remission of the disease.
During their lifetime, 75%–80% of Crohn’s disease pts will require surgical intervention, most commonly ileocecal resection (ICR)
T…